Characteristics and outcomes of a cohort of primary ocular toxoplasmosis
Rabia Bourkiza(Moorfields Eye Hospital NHS Foundation Trust), Mark Westcott(Barts Health NHS Trust), Angela Rees(Moorfields Eye Hospital NHS Foundation Trust), Carlos Pavésio(Moorfields Eye Hospital NHS Foundation Trust), Benedict Girling(Barts Health NHS Trust)
Unknown
July 13, 2018
Cited by 0
Related Papers
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
|Lara D. Veeken|2008|149
British Ocular Syphilis Study (BOSS): 2-Year National Surveillance Study of Intraocular Inflammation Secondary to Ocular Syphilis
|Investigative Ophthalmology & Visual Science|2014|138
Viral posterior uveitis
|Survey of Ophthalmology|2016|126
Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis
|Survey of Ophthalmology|2016|110
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs
|British Journal of Ophthalmology|2020|106